European Journal of Cancer
Volume 38 , Pages 15-20 , February 2002

Capecitabine as first-line treatment in colorectal cancer: pooled data from two large, phase III trials

  • C Twelves

      Affiliations

    • Corresponding Author InformationTel.: +44-141-211-1712; fax: +44-141-211-1869
    • ,
  • on behalf of the Xeloda Colorectal Cancer Group

Received 25 June 2001 ,Revised 26 November 2001 ,Accepted 29 November 2001.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0959-8049(01)00415-4

European Journal of Cancer
Volume 38 , Pages 15-20 , February 2002

Article Tools

* Image Usage & Resolution